Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis
Identifieur interne : 001F10 ( Ncbi/Curation ); précédent : 001F09; suivant : 001F11Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis
Auteurs : John Backus ; Todd Laughlin ; Yixin Wang ; Robert Belly ; Robert White ; Jon Baden ; C. Justus Min ; Ann Mannie ; Lorraine Tafra ; David Atkins ; Kathryn M. VerbanacSource :
- The Journal of molecular diagnostics : JMD [ 1525-1578 ] ; 2005.
Abstract
Sentinel lymph node (SLN) status is highly predictive of overall axillary lymph node involvement in breast cancer. Historically, SLN-positive patients have undergone axillary lymph node dissection in a second surgery. Intraoperative SLN analysis could reduce the cost and complications of a second surgery; however, existing histopathological methods lack standardization and exhibit poor sensitivity. Rapid molecular methods may lead to improved intraoperative diagnosis of SLN metastasis. In this study, we used a genome-wide gene expression analysis of breast and other tissues to identify seven putative markers for detecting breast cancer metastasis. We assessed the utility of these markers for identifying clinically actionable metastases in lymph nodes through reverse transcriptase-polymerase chain reaction analysis of SLNs from 254 breast cancer patients. Polymerase chain reaction signals were compared to pathology on a per-patient basis. The optimal two-gene combination, mammaglobin and cytokeratin 19, detected clinically actionable metastasis in breast SLNs with 90% sensitivity and 94% specificity. Application of stringent criteria for identifying presumptive hematoxylin- and eosin-positive samples increased sensitivity and specificity to 91 and 97%, respectively. This study represents the first comprehensive demonstration of the utility of gene expression markers for detecting clinically actionable breast metastases. An intraoperative molecular assay using these markers has the potential to significantly reduce second surgeries for patients undergoing SLN dissection.
Url:
PubMed: 16049304
PubMed Central: 1867547
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000B73
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000B72
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003D62
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001F10
Links to Exploration step
PMC:1867547Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis</title>
<author><name sortKey="Backus, John" sort="Backus, John" uniqKey="Backus J" first="John" last="Backus">John Backus</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Laughlin, Todd" sort="Laughlin, Todd" uniqKey="Laughlin T" first="Todd" last="Laughlin">Todd Laughlin</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wang, Yixin" sort="Wang, Yixin" uniqKey="Wang Y" first="Yixin" last="Wang">Yixin Wang</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Belly, Robert" sort="Belly, Robert" uniqKey="Belly R" first="Robert" last="Belly">Robert Belly</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="White, Robert" sort="White, Robert" uniqKey="White R" first="Robert" last="White">Robert White</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Baden, Jon" sort="Baden, Jon" uniqKey="Baden J" first="Jon" last="Baden">Jon Baden</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Min, C Justus" sort="Min, C Justus" uniqKey="Min C" first="C. Justus" last="Min">C. Justus Min</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mannie, Ann" sort="Mannie, Ann" uniqKey="Mannie A" first="Ann" last="Mannie">Ann Mannie</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Tafra, Lorraine" sort="Tafra, Lorraine" uniqKey="Tafra L" first="Lorraine" last="Tafra">Lorraine Tafra</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Atkins, David" sort="Atkins, David" uniqKey="Atkins D" first="David" last="Atkins">David Atkins</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Verbanac, Kathryn M" sort="Verbanac, Kathryn M" uniqKey="Verbanac K" first="Kathryn M." last="Verbanac">Kathryn M. Verbanac</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">16049304</idno>
<idno type="pmc">1867547</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1867547</idno>
<idno type="RBID">PMC:1867547</idno>
<date when="2005">2005</date>
<idno type="wicri:Area/Pmc/Corpus">000B73</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000B73</idno>
<idno type="wicri:Area/Pmc/Curation">000B72</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000B72</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003D62</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003D62</idno>
<idno type="wicri:Area/Ncbi/Merge">001F10</idno>
<idno type="wicri:Area/Ncbi/Curation">001F10</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis</title>
<author><name sortKey="Backus, John" sort="Backus, John" uniqKey="Backus J" first="John" last="Backus">John Backus</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Laughlin, Todd" sort="Laughlin, Todd" uniqKey="Laughlin T" first="Todd" last="Laughlin">Todd Laughlin</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Wang, Yixin" sort="Wang, Yixin" uniqKey="Wang Y" first="Yixin" last="Wang">Yixin Wang</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Belly, Robert" sort="Belly, Robert" uniqKey="Belly R" first="Robert" last="Belly">Robert Belly</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="White, Robert" sort="White, Robert" uniqKey="White R" first="Robert" last="White">Robert White</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Baden, Jon" sort="Baden, Jon" uniqKey="Baden J" first="Jon" last="Baden">Jon Baden</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Min, C Justus" sort="Min, C Justus" uniqKey="Min C" first="C. Justus" last="Min">C. Justus Min</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Mannie, Ann" sort="Mannie, Ann" uniqKey="Mannie A" first="Ann" last="Mannie">Ann Mannie</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Tafra, Lorraine" sort="Tafra, Lorraine" uniqKey="Tafra L" first="Lorraine" last="Tafra">Lorraine Tafra</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Atkins, David" sort="Atkins, David" uniqKey="Atkins D" first="David" last="Atkins">David Atkins</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
<author><name sortKey="Verbanac, Kathryn M" sort="Verbanac, Kathryn M" uniqKey="Verbanac K" first="Kathryn M." last="Verbanac">Kathryn M. Verbanac</name>
<affiliation><nlm:aff id="N0x364e2d0N0x3d59aa8"></nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of molecular diagnostics : JMD</title>
<idno type="ISSN">1525-1578</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Sentinel lymph node (SLN) status is highly predictive of overall axillary lymph node involvement in breast cancer. Historically, SLN-positive patients have undergone axillary lymph node dissection in a second surgery. Intraoperative SLN analysis could reduce the cost and complications of a second surgery; however, existing histopathological methods lack standardization and exhibit poor sensitivity. Rapid molecular methods may lead to improved intraoperative diagnosis of SLN metastasis. In this study, we used a genome-wide gene expression analysis of breast and other tissues to identify seven putative markers for detecting breast cancer metastasis. We assessed the utility of these markers for identifying clinically actionable metastases in lymph nodes through reverse transcriptase-polymerase chain reaction analysis of SLNs from 254 breast cancer patients. Polymerase chain reaction signals were compared to pathology on a per-patient basis. The optimal two-gene combination, mammaglobin and cytokeratin 19, detected clinically actionable metastasis in breast SLNs with 90% sensitivity and 94% specificity. Application of stringent criteria for identifying presumptive hematoxylin- and eosin-positive samples increased sensitivity and specificity to 91 and 97%, respectively. This study represents the first comprehensive demonstration of the utility of gene expression markers for detecting clinically actionable breast metastases. An intraoperative molecular assay using these markers has the potential to significantly reduce second surgeries for patients undergoing SLN dissection.</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F10 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001F10 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:1867547 |texte= Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:16049304" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |